|
|||||
|
|
Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials |
|
| Authors: | Medha Munshi MD Robert Ritzel MD Edward B Jude MD Terry Dex PharmD Lydie Melas-Melt MSc Julio Rosenstock MD |
| Affiliation: | 1. Joslin Diabetes Center, Boston, Massachusetts, USA;2. Klinikum Schwabing and Klinikum Bogenhausen, Munich, Germany;3. Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton under Lyne and University of Manchester/Manchester Metropolitan University, Manchester, UK;4. Sanofi, Bridgewater, New Jersey, USA;5. Ividata Life Sciences, Levallois-Perret, France;6. Velocity Clinical Research at Medical City, Dallas, Texas, USA |
| Abstract: | |
| Keywords: | iGlarLixi LixiLan older people SoliMix type 2 diabetes |